| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.041 | 0.8 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |